Arends JE - Search Results

1

High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.

Hakkers CS, Hermans AM, van Maarseveen EM, Teunissen CE, Verberk IMW, Arends JE, Hoepelman AIM. Hakkers CS, et al. Among authors: arends je. J Neurovirol. 2020 Aug;26(4):572-580. doi: 10.1007/s13365-020-00860-1. Epub 2020 Jun 10. J Neurovirol. 2020. PMID: 32524424 Free PMC article. Clinical Trial.

2

Peginterferon monotherapy for the treatment of acute hepatitis C in HIV-coinfected patients.

Arends JE, Schrover IM, Schaar CG, Mudrikova T, Hoepelman AI. Arends JE, et al. AIDS. 2008 Jul 11;22(11):1381-2. doi: 10.1097/QAD.0b013e3283036cac. AIDS. 2008. PMID: 18580623 No abstract available.

3

T-cell responses at baseline and during therapy with peginterferon-alpha and ribavirin are not associated with outcome in chronic hepatitis C infected patients.

Arends JE, Claassen MA, van den Berg CH, Nanlohy NM, van Erpecum KJ, Baak BC, Hoepelman AI, Boonstra A, van Baarle D. Arends JE, et al. Antiviral Res. 2010 Sep;87(3):353-60. doi: 10.1016/j.antiviral.2010.06.002. Epub 2010 Jun 12. Antiviral Res. 2010. PMID: 20547185

4

Letter to Mendeni et al.

van der Pas VR, Hoepelman AI, Arends JE. van der Pas VR, et al. Among authors: arends je. Clin Infect Dis. 2011 Sep;53(6):613-4; author reply 614-5. doi: 10.1093/cid/cir479. Clin Infect Dis. 2011. PMID: 21865198 No abstract available.

5

Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.

Arends JE, Fransen JH, Hoepelman AI, van Baarle D. Arends JE, et al. Int J Antimicrob Agents. 2011 Dec;38(6):538-9. doi: 10.1016/j.ijantimicag.2011.08.010. Epub 2011 Oct 4. Int J Antimicrob Agents. 2011. PMID: 21974859

6

Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C.

Arends JE, van Assen S, Stek CJ, Wensing AM, Fransen JH, Schellens IM, Spijkers SN, Mudrikova T, van Baarle D, Sprenger HG, Hoepelman AI. Arends JE, et al. Antivir Ther. 2011;16(7):979-88. doi: 10.3851/IMP1843. Antivir Ther. 2011. PMID: 22024513

7

Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humans.

van Maarseveen NM, Wensing AM, de Jong D, Beilhartz GL, Obikhod A, Tao S, Pingen M, Arends JE, Hoepelman AI, Schinazi RF, Götte M, Nijhuis M. van Maarseveen NM, et al. Among authors: arends je. Antivir Ther. 2011;16(7):1123-30. doi: 10.3851/IMP1912. Antivir Ther. 2011. PMID: 22024528 Free PMC article.

8

Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort.

van Lelyveld SF, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AM, Hoepelman AI; ATHENA national observational cohort study. van Lelyveld SF, et al. AIDS. 2012 Feb 20;26(4):465-74. doi: 10.1097/QAD.0b013e32834f32f8. AIDS. 2012. PMID: 22112603

9

Hepatitis B viral load and risk of HBV-related liver disease: from East to West?

Harkisoen S, Arends JE, van Erpecum KJ, van den Hoek A, Hoepelman AI. Harkisoen S, et al. Among authors: arends je. Ann Hepatol. 2012 Mar-Apr;11(2):164-71. Ann Hepatol. 2012. PMID: 22345332 Free article. Review.

10

Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients.

van Welzen BJ, Verduyn Lunel FM, Meindertsma F, Hoepelman AI, Arends JE. van Welzen BJ, et al. Among authors: arends je. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e65-7. doi: 10.1097/QAI.0b013e318251b01f. J Acquir Immune Defic Syndr. 2012. PMID: 22622079 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page